Behind the numbers: AstraZeneca aims for sales of $80 billion by 2030

Gavin MaguireJanuary 6, 2021January 6, 2021

Gavin MaguireFebruary 15, 2021February 15, 2021

Gavin MaguireFebruary 22, 2021February 22, 2021

Gavin MaguireFebruary 28, 2021March 1, 2021

Gavin MaguireMarch 18, 2021March 18, 2021

Gavin MaguireMarch 21, 2021March 21, 2021